Mikhail Krasavin

6.3k total citations · 1 hit paper
341 papers, 4.7k citations indexed

About

Mikhail Krasavin is a scholar working on Organic Chemistry, Molecular Biology and Cancer Research. According to data from OpenAlex, Mikhail Krasavin has authored 341 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 270 papers in Organic Chemistry, 135 papers in Molecular Biology and 56 papers in Cancer Research. Recurrent topics in Mikhail Krasavin's work include Synthesis and Catalytic Reactions (98 papers), Cyclopropane Reaction Mechanisms (63 papers) and Synthesis and Biological Activity (56 papers). Mikhail Krasavin is often cited by papers focused on Synthesis and Catalytic Reactions (98 papers), Cyclopropane Reaction Mechanisms (63 papers) and Synthesis and Biological Activity (56 papers). Mikhail Krasavin collaborates with scholars based in Russia, Italy and Australia. Mikhail Krasavin's co-authors include Dmitry Dar’in, Grigory Kantin, Olga Bakulina, Ewgenij Proschak, Kerstin Hiesinger, Evgeny Chupakhin, Claudiu T. Supuran, Stanislav Kalinin, Alexander Sapegin and Alexander Prosekov and has published in prestigious journals such as SHILAP Revista de lepidopterología, Chemical Communications and International Journal of Molecular Sciences.

In The Last Decade

Mikhail Krasavin

334 papers receiving 4.6k citations

Hit Papers

Spirocyclic Scaffolds in Medicinal Chemistry 2020 2026 2022 2024 2020 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Spirocyclic Scaffolds in Medicinal Chemistry
    2020 420 citations Dmitry Dar’in, Mikhail Krasavin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mikhail Krasavin Russia 30 3.7k 1.6k 447 414 247 341 4.7k
José M. Padrón Spain 31 2.2k 0.6× 1.5k 0.9× 138 0.3× 458 1.1× 222 0.9× 240 3.9k
Mouâd Alami France 51 6.9k 1.9× 1.7k 1.1× 151 0.3× 417 1.0× 113 0.5× 251 8.0k
Yoshiharu Iwabuchi Japan 44 4.7k 1.3× 2.0k 1.3× 252 0.6× 465 1.1× 360 1.5× 218 6.4k
Masataka Ihara Japan 41 5.5k 1.5× 1.8k 1.1× 256 0.6× 528 1.3× 354 1.4× 400 7.0k
Michel Baltas France 31 1.9k 0.5× 1.2k 0.7× 79 0.2× 271 0.7× 126 0.5× 143 3.1k
Dmitry Dar’in Russia 23 2.1k 0.6× 521 0.3× 374 0.8× 126 0.3× 192 0.8× 230 2.8k
Gian Cesare Tron Italy 38 4.2k 1.1× 2.4k 1.5× 113 0.3× 347 0.8× 99 0.4× 131 5.9k
Takashi Matsumoto Japan 40 4.4k 1.2× 2.3k 1.4× 220 0.5× 779 1.9× 352 1.4× 343 6.0k
Toshio Honda Japan 34 3.4k 0.9× 1.6k 1.0× 160 0.4× 493 1.2× 365 1.5× 358 5.0k
George A. O’Doherty United States 43 4.2k 1.1× 2.7k 1.7× 199 0.4× 1.0k 2.5× 562 2.3× 186 5.3k

Countries citing papers authored by Mikhail Krasavin

Since Specialization
Citations

This map shows the geographic impact of Mikhail Krasavin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikhail Krasavin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikhail Krasavin more than expected).

Fields of papers citing papers by Mikhail Krasavin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikhail Krasavin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikhail Krasavin. The network helps show where Mikhail Krasavin may publish in the future.

Co-authorship network of co-authors of Mikhail Krasavin

This figure shows the co-authorship network connecting the top 25 collaborators of Mikhail Krasavin. A scholar is included among the top collaborators of Mikhail Krasavin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikhail Krasavin. Mikhail Krasavin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vinogradova, Tatiana, et al.. (2023). Urea derivatives of spirocyclic piperidines endowed with antibacterial activity. Mendeleev Communications. 33(1). 109–111. 1 indexed citations
2.
Kalinin, Stanislav, Dmitry Dar’in, Maxim Gureev, et al.. (2023). A new way of synthesizing heterocyclic primary sulfonamide probes for carbonic anhydrase. Mendeleev Communications. 33(3). 325–327. 1 indexed citations
3.
Krasavin, Mikhail, et al.. (2023). Spirocyclic azetidines for drug discovery: Novel Boc-protected 7'H-spiro[azetidine-3,5'-furo[3,4-d ]pyrimidines]. Mendeleev Communications. 33(3). 323–324. 2 indexed citations
4.
Kantin, Grigory, et al.. (2023). Rh(II)-catalyzed condensation of 3-diazotetramic acids with nitriles delivers novel druglike 5,6-dihydro-4H-pyrrolo[3,4-d]oxazol-4-ones. Tetrahedron Letters. 120. 154457–154457. 2 indexed citations
5.
6.
Rodionov, Ivan A., et al.. (2023). Catalyst Loading Controls Chemoselectivity: Unusual Effect in Rhodium(II) Carbene Insertion Reactions with Tetrahydrofuran. Catalysts. 13(2). 428–428. 1 indexed citations
7.
Krasavin, Mikhail, Anatoly A. Peshkov, Evgeniya V. Efimova, et al.. (2022). Discovery and In Vivo Efficacy of Trace Amine-Associated Receptor 1 (TAAR1) Agonist 4-(2-Aminoethyl)-N-(3,5-dimethylphenyl)piperidine-1-carboxamide Hydrochloride (AP163) for the Treatment of Psychotic Disorders. International Journal of Molecular Sciences. 23(19). 11579–11579. 7 indexed citations
8.
Sapegin, Alexander, Л. А. Краева, Maxim Gureev, et al.. (2022). Novel 5-Nitrofuran-Tagged Imidazo-Fused Azines and Azoles Amenable by the Groebke–Blackburn–Bienaymé Multicomponent Reaction: Activity Profile against ESKAPE Pathogens and Mycobacteria. Biomedicines. 10(9). 2203–2203. 3 indexed citations
9.
Dar’in, Dmitry, et al.. (2022). A novel spirocyclic scaffold accessed via tandem Claisen rearrangement/intramolecular oxa-Michael addition. Beilstein Journal of Organic Chemistry. 18. 1649–1655. 2 indexed citations
10.
Nocentini, Alessio, Maxim Gureev, Arto Urtti, et al.. (2022). 5-(Sulfamoyl)thien-2-yl 1,3-oxazole inhibitors of carbonic anhydrase II with hydrophilic periphery. Journal of Enzyme Inhibition and Medicinal Chemistry. 37(1). 1005–1011. 7 indexed citations
11.
Dar’in, Dmitry, et al.. (2021). 1-Oxo-3,4-dihydroisoquinoline-4-carboxamides as novel druglike inhibitors of poly(ADP-ribose) polymerase (PARP) with favourable ADME characteristics. Journal of Enzyme Inhibition and Medicinal Chemistry. 36(1). 1968–1983. 2 indexed citations
12.
Mirzaei, Saber, Frank Röminger, Dmitry Dar’in, et al.. (2021). Synthesis of Spiro[chromene-imidazo[1,2-a]pyridin]-3′-imines via 6-exo-dig Cyclization Reaction. The Journal of Organic Chemistry. 86(19). 13693–13701. 12 indexed citations
13.
Dar’in, Dmitry, et al.. (2021). Three-component Castagnoli-Cushman reaction with ammonium acetate delivers 2-unsubstituted isoquinol-1-ones as potent inhibitors of poly(ADP-ribose) polymerase (PARP). Journal of Enzyme Inhibition and Medicinal Chemistry. 36(1). 1916–1921. 5 indexed citations
14.
Supuran, Claudiu T., et al.. (2021). Biochemical profiling of anti-HIV prodrug Elsulfavirine (Elpida®) and its active form VM1500A against a panel of twelve human carbonic anhydrase isoforms. Journal of Enzyme Inhibition and Medicinal Chemistry. 36(1). 1056–1060. 6 indexed citations
15.
Dar’in, Dmitry, Л. А. Краева, Oleg V. Levin, et al.. (2020). Mutually Isomeric 2- and 4-(3-Nitro-1,2,4-triazol-1-yl)pyrimidines Inspired by an Antimycobacterial Screening Hit: Synthesis and Biological Activity against the ESKAPE Panel of Pathogens. Antibiotics. 9(10). 666–666. 5 indexed citations
16.
Dubovtsev, Alexey Yu., Dmitry Dar’in, Mikhail Krasavin, & Vadim Yu. Kukushkin. (2019). Gold‐Catalyzed Oxidation of Internal Alkynes into Benzils and its Application for One‐Pot Synthesis of Five‐, Six‐, and Seven‐Membered Azaheterocycles. European Journal of Organic Chemistry. 2019(8). 1856–1864. 43 indexed citations
17.
Шетнев, Антон А., Sergey V. Baykov, Stanislav Kalinin, et al.. (2019). 1,2,4-Oxadiazole/2-Imidazoline Hybrids: Multi-target-directed Compounds for the Treatment of Infectious Diseases and Cancer. International Journal of Molecular Sciences. 20(7). 1699–1699. 36 indexed citations
18.
Bolotin, Dmitrii S., Viktor Korzhikov‐Vlakh, Vitalii V. Suslonov, et al.. (2019). Biocompatible zinc(II) 8-(dihydroimidazolyl)quinoline complex and its catalytic application for synthesis of poly(L,L-lactide). Journal of Catalysis. 372. 362–369. 4 indexed citations
19.
Kalinin, Stanislav, Alessio Nocentini, Vladimir V. Sharoyko, et al.. (2019). From random to rational: A discovery approach to selective subnanomolar inhibitors of human carbonic anhydrase IV based on the Castagnoli-Cushman multicomponent reaction. European Journal of Medicinal Chemistry. 182. 111642–111642. 16 indexed citations
20.
Krasavin, Mikhail, Антон А. Шетнев, Sergey V. Baykov, et al.. (2018). Continued exploration of 1,2,4-oxadiazole periphery for carbonic anhydrase-targeting primary arene sulfonamides: Discovery of subnanomolar inhibitors of membrane-bound hCA IX isoform that selectively kill cancer cells in hypoxic environment. European Journal of Medicinal Chemistry. 164. 92–105. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José M. Padrón Breakdown of academic impact, for papers by Mouâd Alami Breakdown of academic impact, for papers by Yoshiharu Iwabuchi Breakdown of academic impact, for papers by Masataka Ihara Breakdown of academic impact, for papers by Michel Baltas Breakdown of academic impact, for papers by Dmitry Dar’in Breakdown of academic impact, for papers by Gian Cesare Tron Breakdown of academic impact, for papers by Takashi Matsumoto Breakdown of academic impact, for papers by Toshio Honda Breakdown of academic impact, for papers by George A. O’Doherty
Rankless by CCL
2026